Main > NEUROLOGY. > Epilepsy > Treatment > Co: PT. B. Eslicarbazepine Acetate > (*) USA 2nd Approval: 2017. 09.14.>

---

(*) USA 2nd Approval: 2017. 09.14.>'s subsections
>POSs.>4 to 17 Years of Age

(*) USA 2nd Approval: 2017. 09.14.>'s products
This section has no products